Published in J Am Geriatr Soc on August 01, 1991
Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol (2011) 1.45
Cognitive function in the oldest old: women perform better than men. J Neurol Neurosurg Psychiatry (2001) 1.44
Alzheimer's and dementia in the oldest-old: a century of challenges. Curr Alzheimer Res (2006) 1.20
Are cognitively impaired individuals adequately represented in community surveys? Recruitment challenges and strategies to facilitate participation in community surveys of older adults. A review. Eur J Epidemiol (2000) 1.03
Cataract and cognitive impairment: a review of the literature. Br J Ophthalmol (2010) 0.95
Dementia in the oldest old: a multi-factorial and growing public health issue. Alzheimers Res Ther (2013) 0.87
Physical activity and risk of cognitive impairment among oldest-old women. Am J Geriatr Psychiatry (2013) 0.82
A Population-based study of dementia in the oldest old: the Monzino 80-plus study. BMC Neurol (2011) 0.81
Reduced prevalence of cognitive impairment in families with exceptional longevity. JAMA Neurol (2013) 0.81
An immunofluorescence procedure for the detection of intracellular immunoglobulins. Clin Exp Immunol (1969) 4.77
Successful aging in the oldest old: Who can be characterized as successfully aged? Arch Intern Med (2001) 3.16
Pathological changes of thymic epithelial cells and autoimmune disease in NZB, NZW and (NZB x NZW)F1 mice. Immunology (1967) 2.88
The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity. Immunology (1966) 2.83
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol (1981) 2.54
Total cholesterol and risk of mortality in the oldest old. Lancet (1997) 2.50
The immunological development of the human fetus. J Exp Med (1965) 2.44
The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions. Immunology (1966) 2.40
Statins for prevention of stroke. Lancet (1998) 2.26
A high response is not essential to prevent selection bias: results from the Leiden 85-plus study. J Clin Epidemiol (2002) 2.24
Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev (1984) 2.22
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Independent movement of IgD and IgM molecules on the surface of individual lymphocytes. J Immunol (1973) 2.03
Recent developments in immunofluorescence. Prog Allergy (1972) 2.02
Impact of mild cognitive impairment on survival in very elderly people: cohort study. BMJ (1997) 1.91
Reference values for the Mini-Mental State Examination (MMSE) in octo- and nonagenarians. J Am Geriatr Soc (1990) 1.89
Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke (1997) 1.86
Quantitative immunofluorescence. Standardization and calibration in microfluorometry. Histochemie (1971) 1.69
An immunofluorescence study on intracellular immunoglobulins in human bone marrow cells. Ann N Y Acad Sci (1971) 1.67
A community-based study of survival in dementia. Acta Psychiatr Scand (1992) 1.58
The formation of immunoglobulins by human tissues in vitro. 3. Spleen, lymph nodes, bone marrow and thymus. Immunology (1966) 1.53
Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol (1975) 1.41
Prevalence of subjective dysphagia in community residents aged over 87. BMJ (1990) 1.38
An immunological study during post-transplantation follow-up of a case of severe combined immunodeficiency. Clin Exp Immunol (1972) 1.29
Cryoglobulins in New Zealand Black mice. Clin Exp Immunol (1969) 1.28
A deficient development of the thymic epithelium and auto-immune disease in NZB mice. J Pathol Bacteriol (1966) 1.23
Alpha-chain disease with involvement of the respiratory tract in a Dutch child. Clin Exp Immunol (1971) 1.22
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet (1993) 1.18
Serum immunoglobulin levels in twins. Clin Exp Immunol (1969) 1.18
Immunoglobulin-containing cells in different lymphoid organs of the CBA mouse during its life-span. Immunology (1977) 1.17
The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia. Br J Haematol (1966) 1.15
Microfluorometric evaluation of the specificity of fluorescent antisera against mouse immunoglobulins with the defined antigen substrate spheres (DASS) system. J Immunol Methods (1976) 1.14
Disability in the oldest old: "can do" or "do do"? J Am Geriatr Soc (2001) 1.14
Idiopathic senile gait disorders are signs of subclinical disease. J Am Geriatr Soc (2000) 1.13
Binding of secretory piece to polymeric IgA and IgM paraproteins in vitro. Immunology (1971) 1.12
Persistance in mice of the L-phase of three streptococcal strains adapted to physiological osmotic conditions. J Gen Microbiol (1970) 1.11
The origin of monomeric and polymeric forms of IgA in man. Adv Exp Med Biol (1974) 1.11
The determination of numbers of T and B lymphocytes in the blood of children and adults by the direct immunofluorescence technique. Clin Exp Immunol (1977) 1.09
Immunofluorescence studies on immunoglobulins in the lymphoid cells of human peripheral blood. Clin Exp Immunol (1972) 1.08
Identification of mononuclear cells in human blood. I. Qualitative and quantitative data on surface markers after formaldehyde fixation of the cells. Clin Exp Immunol (1980) 1.07
Validation of medical history taking as part of a population based survey in subjects aged 85 and over. BMJ (1992) 1.05
The relation between class-specific serum rheumatoid factors and age in the general population. Br J Rheumatol (1993) 1.05
The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood. Immunology (1986) 1.04
Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev (1990) 1.04
Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol (1992) 1.02
Levels of the serum amyloid A protein (SAA) in normal persons of different age groups. Clin Exp Immunol (1979) 0.99
The cellular basis of double paraproteinemia in man. Clin Immunol Immunopathol (1978) 0.98
Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech Ageing Dev (1990) 0.97
Autoantibodies in highly aged humans. Mech Ageing Dev (1984) 0.97
Influence of age on the immunological activity and capacity of the CBA mouse. Mech Ageing Dev (1978) 0.97
Regulation of the "spontaneous' (background) immunoglobulin synthesis. Int Arch Allergy Appl Immunol (1981) 0.96
An immunofluorescence study on the specificity of antibodies synthesized in separate cells after the administration of an immunogen with double specificity. Eur J Immunol (1972) 0.96
Subpopulations of mononuclear cells in ageing: expansion of the null cell compartment and decrease in the number of T and B cells in human blood. Immunology (1985) 0.96
Blast cell leukaemia associated with IgA paraproteinaemia and Bence Jones protein. Br J Haematol (1970) 0.95
Presence of multiple isotypes on the surface of human tonsillar lymphocytes. Eur J Immunol (1980) 0.95
Multiple heavy chain isotypes on the membrane of the small B lymphocytes in human blood. Clin Exp Immunol (1981) 0.92
A chemically defined medium for the L-phase of group A streptococci. Ann N Y Acad Sci (1967) 0.92
Identification of mononuclear cells in human blood. II. Evaluation of morphological and immunological aspects of native and formaldehyde-fixed cell populations. Clin Exp Immunol (1980) 0.91
The prevalence of morbidity in the oldest old, aged 85 and over: a population-based survey in Leiden, The Netherlands. Arch Gerontol Geriatr (2004) 0.91
The long-term antibody response of New Zealand Black mice to sheep red blood cells. Immunology (1974) 0.90
Cytoplasmic immunofluorescence of bone marrow plasma cells producing immunoglobulins of the four IgG subclasses. J Immunol (1975) 0.89
Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis. Clin Exp Immunol (1974) 0.88
Age-related decline in the antibody response to E. coli lipopolysaccharide in New Zealand Black mice. Immunology (1975) 0.88
Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR). Eur J Hum Genet (1999) 0.88
Cell markers in hairy cell leukemia studied in cells from 51 patients. Blood (1982) 0.87
Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle. Clin Exp Immunol (1973) 0.87
Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood. Immunology (1989) 0.87
Gating of the so-called 'lymphocytic' cell population for the quantification of natural killer cells (CD16+) by flow cytometry causes loss of CD16 positive cells. J Immunol Methods (1990) 0.86
Hairy-cell leukaemia: a B-lymphocytic disorder. Br J Haematol (1979) 0.86
Review: cobalamin deficiency and mental impairment in elderly people. Age Ageing (1995) 0.86
Further evidence for the lymphocytic nature of leukaemic reticuloendotheliosis (hairy-cell leukaemia). Br J Haematol (1974) 0.85
Rheumatoid arthritis in a population of persons aged 85 years and over. Br J Rheumatol (1993) 0.85
The development of lymphocytes with T- or B-membrane determinants in the human foetus. Clin Exp Immunol (1977) 0.85
The specificity of commercial conjugates to human immunoglobulins: results of performance tests on monoclonal and polyclonal plasma cells and lymphocytes. J Immunol Methods (1981) 0.84
Light and electron microscopic studies of the rat hyalocyte after perfusion fixation. Ophthalmic Res (1985) 0.83
Immunoglobulin analysis in families of macroglobulinaemia patients. Clin Exp Immunol (1969) 0.83
Intracellular inclusion bodies in 14 patients with B cell lymphoproliferative disorders. J Clin Pathol (1984) 0.83
Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans. Mech Ageing Dev (1992) 0.82
Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann N Y Acad Sci (1994) 0.82
The general population prevalence of non-organic psychiatric disorders in subjects aged 85 years and over. Psychol Med (1992) 0.82
Waldenström's disease with an IgA paraprotein. Acta Med Scand (1975) 0.80
Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis (2000) 0.80
Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85. J Neurol Neurosurg Psychiatry (1999) 0.80
Ambulatory monitoring of sleep-wakefulness patterns in healthy elderly males and females (greater than 88 years): the "Senieur" protocol. J Am Geriatr Soc (1992) 0.79
Relative avidity of antibodies towards sheep red blood cells in New Zealand Black mice. Immunology (1974) 0.79
Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin. Mech Ageing Dev (1992) 0.79
Psychiatric consultations in a Dutch university hospital: a report on 1814 referrals, compared with a literature review. Gen Hosp Psychiatry (1984) 0.79
Alpha chain determinants on the membrane of immunoglobulin synthesizing cells. Adv Exp Med Biol (1974) 0.78
Hairy cell leukemia: its place among the chronic B cell leukemias. Semin Oncol (1984) 0.78
Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T-cell proliferation in individuals who met the health criteria of the Senieur protocol. Mech Ageing Dev (1992) 0.77
Longevity and heredity in humans. Association with the human leucocyte antigen phenotype. Ann N Y Acad Sci (1991) 0.77
[Gait impairment in the oldest old]. Tijdschr Gerontol Geriatr (1997) 0.77
HMG-CoA reductase inhibitors in the prevention of stroke. Drugs (2000) 0.76
Intracellular immunoglobulin G 'pseudocrystals' in a patient with chronic B-cell leukemia. Cancer (1986) 0.75
Surface bound or cytoplasmic immunoglobulins: interpretation of the immunofluorescence observed in cytocentrifuge slides of human lymphocytes. Clin Exp Immunol (1984) 0.75
Family studies in Waldenström's macroglobulinaemia. Ned Tijdschr Geneeskd (1966) 0.75